Milan Kovacevic
Career history of Milan Kovacevic
Former positions of Milan Kovacevic
| Companies | Position | Start | End |
|---|---|---|---|
| GENVEC INC | Chief Tech/Sci/R&D Officer | 21/07/2009 | - |
Kendle International LLC
 Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - | - |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | - | - |
| SYNVISTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Milan Kovacevic
| University of Belgrade | Graduate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
| Serbia, Republic of | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNVISTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Milan Kovacevic
- Experience
